Free Trial

Compare Stocks

→ What is Medicare Supplement Insurance? (From Tranzact) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Compare

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
C$1.32
+5.6%		C$1.32
C$0.80
▼
C$4.06
C$256.62MN/A1.51 million shs310,601 shs
Arno Therapeutics, Inc. stock logo
ARNI
Arno Therapeutics
$0.00
$0.00
$0.00
▼
$0.00
N/AN/A8,820 shsN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
$0.00
$0.00
▼
$0.00
N/AN/A11,650 shs2,500 shs
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
0.00%0.00%0.00%0.00%0.00%
Arno Therapeutics, Inc. stock logo
ARNI
Arno Therapeutics
0.00%+200.00%+200.00%+200.00%-85.71%
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/AN/AN/AN/AN/AN/AN/AN/A
Arno Therapeutics, Inc. stock logo
ARNI
Arno Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/AN/AN/AN/A
Arno Therapeutics, Inc. stock logo
ARNI
Arno Therapeutics
N/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/AN/AN/AN/AN/AN/A
Arno Therapeutics, Inc. stock logo
ARNI
Arno Therapeutics
N/AN/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/AN/A0.00∞N/AN/AN/AN/AN/A
Arno Therapeutics, Inc. stock logo
ARNI
Arno Therapeutics
N/A-$0.23N/A∞N/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/A-$0.16N/AN/AN/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/AN/AN/AN/AN/A
Arno Therapeutics, Inc. stock logo
ARNI
Arno Therapeutics
N/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/A
Arno Therapeutics, Inc. stock logo
ARNI
Arno Therapeutics
34.27%
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
32.45%

Insider Ownership

CompanyInsider Ownership
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/A
Arno Therapeutics, Inc. stock logo
ARNI
Arno Therapeutics
11.15%
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/A194.41 millionN/ANot Optionable
Arno Therapeutics, Inc. stock logo
ARNI
Arno Therapeutics
4N/AN/ANot Optionable
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/ANot Optionable

ARNI, ATTBF, ABCN, ABZA, and AHZ Headlines

SourceHeadline
Abattis Bioceuticals Corp ATTBFAbattis Bioceuticals Corp ATTBF
morningstar.com - November 11 at 8:24 AM
Illumina AktieIllumina Aktie
finanzen100.de - June 28 at 8:57 PM
How a Jungle Prison Became a Famous SpaceportHow a Jungle Prison Became a Famous Spaceport
smithsonianmag.com - June 24 at 12:03 AM
Isotretinoin Price of 93 BrandsIsotretinoin Price of 93 Brands
medindia.net - May 9 at 12:56 PM
Ivermectin Price of 102 BrandsIvermectin Price of 102 Brands
medindia.net - April 20 at 12:36 PM
Abattis Bioceuticals Corp ATTBF SustainabilityAbattis Bioceuticals Corp ATTBF Sustainability
morningstar.com - September 9 at 10:20 PM
When Will New Jerseys Marijuana Sales Begin? Whats Next After Yet Another Delay?When Will New Jersey's Marijuana Sales Begin? What's Next After Yet Another Delay?
benzinga.com - March 27 at 6:36 PM
Cannabis Payments Co Launches Women In Finance & Technology ScholarshipCannabis Payments Co Launches Women In Finance & Technology Scholarship
benzinga.com - March 26 at 8:52 PM
Charlottes Web Q4 Revenue Up 5% QoQ, Adjusted EBITDA Loss Improves By $5MCharlotte's Web Q4 Revenue Up 5% QoQ, Adjusted EBITDA Loss Improves By $5M
benzinga.com - March 25 at 11:58 PM
Federal Marijuana Cases Drop Again In 2021 As More States LegalizeFederal Marijuana Cases Drop Again In 2021 As More States Legalize
benzinga.com - March 20 at 10:08 PM
Schwazze Common Shares Will Trade On NEO Exchange Under Symbol SHWZ In Late MarchSchwazze Common Shares Will Trade On NEO Exchange Under Symbol 'SHWZ' In Late March
benzinga.com - March 20 at 10:08 PM
MDXclusive Launches Lab-Tested Topical And Sublingual CBD ProductsMDXclusive Launches Lab-Tested Topical And Sublingual CBD Products
benzinga.com - March 9 at 9:22 PM
The Perfect CBD To THC Ratio? New Study Says 1 To 1 Is The Best Ratio For Therapeutic EffectsThe Perfect CBD To THC Ratio? New Study Says 1 To 1 Is The Best Ratio For Therapeutic Effects
benzinga.com - March 6 at 7:27 PM
Most D.C. Workers To Avoid Pre-Employment Marijuana Testing Under New BillMost D.C. Workers To Avoid Pre-Employment Marijuana Testing Under New Bill
benzinga.com - March 5 at 10:25 PM
BDSA Report: Global Cannabis Sales Will Jump 22% In 2022, Grow To $61B By 2026BDSA Report: Global Cannabis Sales Will Jump 22% In 2022, Grow To $61B By 2026
benzinga.com - March 3 at 8:58 PM
Trulieve Files Resale Registration With SEC For Subordinate Voting Shares Of 2021 AcquisitionsTrulieve Files Resale Registration With SEC For Subordinate Voting Shares Of 2021 Acquisitions
benzinga.com - January 26 at 12:56 AM
Latest Issue Of Psychedelics Mag DoubleBlind Plays With The Tension Between Old And NewLatest Issue Of Psychedelics Mag DoubleBlind Plays With The Tension Between Old And New
benzinga.com - December 22 at 6:09 PM
Abattis Bioceuticals Dividend Per Share (TTM)Abattis Bioceuticals Dividend Per Share (TTM)
ycharts.com - December 18 at 12:59 AM
Abattis Bioceuticals EPS Diluted (5 Year Growth)Abattis Bioceuticals EPS Diluted (5 Year Growth)
ycharts.com - December 18 at 12:59 AM
Micah Tapman Of BDSA Lays Out Cannabis Data In The NortheastMicah Tapman Of BDSA Lays Out Cannabis Data In The Northeast
benzinga.com - October 18 at 7:08 PM
Apples Cannabis iPhone App Is Benefiting Businesses And Consumers, Wheres Google Play Store?Apple's Cannabis iPhone App Is Benefiting Businesses And Consumers, Where's Google Play Store?
benzinga.com - September 3 at 9:10 PM
Panama Is Close To Legalizing Medicinal CannabisPanama Is Close To Legalizing Medicinal Cannabis
benzinga.com - August 31 at 6:25 PM
EXCLUSIVE: Healthcare Attorney Brian Rath Discusses Medical Marijuana In Nursing Homes & Assisted Living, Legal? Its ComplicatedEXCLUSIVE: Healthcare Attorney Brian Rath Discusses Medical Marijuana In Nursing Homes & Assisted Living, Legal? It's Complicated
benzinga.com - August 18 at 3:50 AM

New MarketBeat Followers Over Time

Top Headlines

All Headlines

Company Descriptions

VIVO Cannabis logo

VIVO Cannabis

CVE:ABCN
ABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.
Arno Therapeutics logo

Arno Therapeutics

OTCMKTS:ARNI
Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase I clinical study for the treatment of solid tumors and hematological malignancies, as well as in Pre-clinical studies for the treatment of various anti-microbial targets. In addition, the company's product development pipeline comprises AR-42, a novel orally available cancer therapy that is in Phase I investigator-initiated clinical study for the treatment of hematological malignancies and solid tumors. The company has license agreements with Invivis Pharmaceuticals, Inc.; the Regents of the University of Minnesota; and the Ohio State University Innovation Foundation, as well as a co-development agreement with Leica Biosystems Newcastle Ltd. Arno Therapeutics, Inc. was founded in 2005 and is based in Flemington, New Jersey.
Abattis Bioceuticals logo

Abattis Bioceuticals

OTCMKTS:ATTBF
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.